ATE138077T1 - Synthetisches antigen zum bewirken einer anti-hiv-reaktion - Google Patents

Synthetisches antigen zum bewirken einer anti-hiv-reaktion

Info

Publication number
ATE138077T1
ATE138077T1 AT89903389T AT89903389T ATE138077T1 AT E138077 T1 ATE138077 T1 AT E138077T1 AT 89903389 T AT89903389 T AT 89903389T AT 89903389 T AT89903389 T AT 89903389T AT E138077 T1 ATE138077 T1 AT E138077T1
Authority
AT
Austria
Prior art keywords
producing
synthetic antigen
hiv
hiv response
response
Prior art date
Application number
AT89903389T
Other languages
English (en)
Inventor
Jay A Berzofsky
Hidemi Takahashi
Anne Hosmalin
Ronald A Germain
Bernard Moss
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE138077T1 publication Critical patent/ATE138077T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT89903389T 1988-01-26 1989-01-17 Synthetisches antigen zum bewirken einer anti-hiv-reaktion ATE138077T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14869288A 1988-01-26 1988-01-26

Publications (1)

Publication Number Publication Date
ATE138077T1 true ATE138077T1 (de) 1996-06-15

Family

ID=22526912

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89903389T ATE138077T1 (de) 1988-01-26 1989-01-17 Synthetisches antigen zum bewirken einer anti-hiv-reaktion

Country Status (8)

Country Link
EP (1) EP0400076B1 (de)
JP (1) JP2569185B2 (de)
AT (1) ATE138077T1 (de)
AU (1) AU621097B2 (de)
CA (1) CA1340907C (de)
DE (1) DE68926499T2 (de)
IL (1) IL89012A (de)
WO (1) WO1989007112A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030449A (en) * 1988-07-21 1991-07-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthetic vaccine against AIDS virus
US5976541A (en) * 1988-01-26 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
EP0339504A3 (de) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Menschliches immunoinsuffizientes Virus (HIV) env-codiertes Peptid, welches im Stande ist, die HIV hemmenden Antikörper bei Säugetieren hervorzurufen
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5882853A (en) * 1989-09-01 1999-03-16 The United States Of America As Represented By The Department Of Health And Human Services Method of evaluating HTLV-I-specific T cell responses
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
EP1131633A2 (de) 1998-11-16 2001-09-12 Board of Regents, The University of Texas System Hiv spezifische zelleninduktion
US7189800B2 (en) 2001-03-27 2007-03-13 Samuel Bogoch Replikin peptides in rapid replication of glioma cells and in influenza epidemics
US7774144B2 (en) 2001-10-26 2010-08-10 Samuel Bogoch System and method for identifying complex patterns of amino acids
US7894999B2 (en) 2001-03-27 2011-02-22 Samuel Bogoch Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
US7420028B2 (en) 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
AU2002354559B2 (en) * 2001-07-09 2008-07-31 Bogoch, Elenore S. Replikin peptides and uses thereof
US8494781B2 (en) 2003-06-06 2013-07-23 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
US9254315B2 (en) 2004-04-28 2016-02-09 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
WO2008140557A2 (en) 2006-10-24 2008-11-20 Samuel Bogoch A method of predicting influenza outbreaks
JP5675348B2 (ja) 2007-05-30 2015-02-25 ボゴーク，サミュエル 水産養殖における無脊椎動物の病原性感染に対する合成レプリキンペプチド
US9233148B2 (en) 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
AU2012283914A1 (en) 2011-07-20 2014-01-30 Bogoch, Elanore S. Peptides shared among lethal cancers and therapeutic compositions comprising said peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64006B1 (en) * 1984-10-18 1995-06-28 Pasteur Institut Antigens particulary envelope antigens of the virus of lymphadenopathies and of the acquired immune-deficiency syndrome and virus process for producing virus envelope antigens use of said antigens in the preparation of immunogenic compositions or for the diagnosis of the presence of antibodies against this virus
DE3689941D1 (de) * 1985-10-24 1994-08-04 Southwest Found Biomed Res Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
WO1987007616A1 (en) * 1986-06-12 1987-12-17 Biogen N.V. Peptides involved in the pathogenesis of hiv infection
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
AU592258B2 (en) * 1986-12-30 1990-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
ATE122237T1 (de) * 1987-05-29 1995-05-15 Tanox Biosystems Inc Hiv-1 neutralisierende monoklonale antikörper.
IL87391A0 (en) * 1987-08-27 1989-01-31 Repligen Corp Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them

Also Published As

Publication number Publication date
AU3204489A (en) 1989-08-25
CA1340907C (en) 2000-02-22
JP2569185B2 (ja) 1997-01-08
AU621097B2 (en) 1992-03-05
DE68926499T2 (de) 1996-12-19
EP0400076B1 (de) 1996-05-15
IL89012A (en) 1993-07-08
DE68926499D1 (de) 1996-06-20
EP0400076A4 (en) 1991-11-13
EP0400076A1 (de) 1990-12-05
JPH03503166A (ja) 1991-07-18
WO1989007112A1 (en) 1989-08-10

Similar Documents

Publication Publication Date Title
ATE138077T1 (de) Synthetisches antigen zum bewirken einer anti-hiv-reaktion
NO890103L (no) Fremgangsmaate for fremstilling av levende vaksine mot coccidiosis.
IE890343L (en) Ultrasonic contrast agents, process for their preparation and their use as diagnostic and therapeutic agents
IT1236688B (it) Procedimento e dispositivo per la creazione di una miscela combustibile-aria comburente da addurre a una combustione.
DE3783068T2 (de) Medizinische vorrichtung.
ES533263A0 (es) Procedimiento para la preparacion de una vacuna neumococcica multivalente.
EP0261224A4 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
ES490210A0 (es) Un procedimiento par la preparacion de una vacuna de la gri-pe.
IT8047607A0 (it) Composizione a base di idrolisato di lattalbumina per il trattamento e la cura della pelle
IT1067959B (it) Laminato tessile,nonche' procedimento e dispositivo per la sua fabbricazione
DE3788806D1 (de) Kugelförmige hybrid-hiv-antigene.
IT1064609B (it) Impianto endoosseo individuale per odontostomatologia e attrezzo per la rapida e perfetta applicazione al paziente
ES2063154T3 (es) Vacuna asociada por afinidad.
ES2059784T3 (es) Derivado antigeno de la estreptolisina o, su produccion y usos.
DE68918630D1 (de) Ventilation einer Vakuumbehandlungsvorrichtung.
EP0222302A3 (en) Strain of aureobasidium pullulans, preparation process and use
IT7928339A0 (it) Procedimento per la coagulazione di un lattice acquoso di un polimero.
ES2058432T3 (es) Utilizacion de hidroxido de zinc o de hierro para la coadyuvacion de soluciones de antigenos, y soluciones de antigenos coadyuvadas de este modo.
IT7928087A0 (it) Procedimento e dispositivo per la coagulazione di un lattice acquoso di un polimero.
SE7708780L (sv) Fluorsulfonyloxafluoroalkaner, deras derivat, fluorosulfonylolefiner, deras sampolymerer och forfarande for framstellning derav
IT7821727A0 (it) 3-ammino-1-sostituito-1, 2,4-benzotiadiazin-1-ossido, utile quale agente ipotensivo, eprocedimento per la sua preparazione.
IT8622902A0 (it) Procedimento e dispositivo per la messa in tensione di pelli cucite a manicotto, in particolare per il confezionamento di pellicce esimili.
NO973753D0 (no) Helicobacter pylori antigen
NO875231L (no) Fremstilling av copolymerer av polyvinylalkoholer.
FR2580176B1 (fr) Vaccin antirabique avirulent

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time